Avenir Wellness Solutions, Inc. logo

Avenir Wellness Solutions, Inc.

CURR
Last price US$3.24
Market cap US$243.9m
12M price change 45.62%
Loading the 12-month Mave Thesis and 1-month news signal

Dashboard Funda..tals Prediction Screener Map

Avenir Wellness Solutions, Inc. Overview

Industry: -

Sector: -

Avenir Wellness Solutions, Inc., a wellness platform technology company, which develops proprietary wellness, nutraceutical, and topical delivery systems. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid product with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System, a novel dosage form to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. It also sells various wellness products under its distribution partners' brands. In addition, the company develops 50,000IU and Vitamin D3 OTF for oral administration. It has a licensing agreement with Canopy Growth Corporation. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was founded in 2011 and is headquartered in Sherman Oaks, California. Avenir Wellness Solutions, Inc., a wellness platform technology company, which develops proprietary wellness, nutraceutical, and topical delivery systems. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CU Read More

Mavefund brings filings, fundamentals, valuation, price history and news for Avenir Wellness Solutions, Inc. into one research view. The sections below show what strengthens or weakens the research case.

Score

Reported Results

What the company reported, with filing details kept small.

Filed May 04, 2026

Quarterly result summary

Revenue was $7.9M (-15% YoY). Net loss was -$18.5M. Net income was $2.5M (-654% YoY).

Revenue $7.9M -15% YoY
Net loss -$18.5M reported
Net income $2.5M -654% YoY

What changed

  • Revenue -15% YoY to $7.9M.
  • Net income -654% YoY to $2.5M.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

Earnings release Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Prediction-grade evidence

Recent News

Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

No qualified company news in the last 14 days

No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

Earnings Per Share

Score 0/5
Avenir Wellness Solutions, Inc. Financial ratio data is updating.

Return on Equity

Score 0/5
Avenir Wellness Solutions, Inc. Financial ratio data is updating.
Avenir Welln... CURR US$243.9m

Net Margin

Score 0/5
Avenir Wellness Solutions, Inc. Financial ratio data is updating.
Avenir Welln... CURR US$243.9m

Share Buyback

Leverage

Score 0/5
Avenir Wellness Solutions, Inc. F i
Avenir Welln... CURR US$243.9m

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

Verified SEC statements load when this section enters view.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Avenir Wellness Solutions, Inc. logo

Avenir Wellness Solutions, Inc.

US$3.24

US$2.51

-22.4% vs price

US$243.9m

-4.99%

45.62%